T-group (topology)
304.28.2 Multidrug efflux transporter AcrB TolC docking domain
Ligands and drugs
1,345
Member domains
167
with ligand contacts (≤ 4 Å)
12.4% of members
131
with DrugDomain annotations
9.7% of members
95
with a DrugBank compound
7.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 304.28.2 belongs to X-group 304 Alpha-beta plaits, which binds 8.8 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01017 | MIY | Minocycline | 10 |
| DB01045 | RFP | Rifampin | 2 |
| DB17031 | ET | Homidium | 2 |
| DB00537 | CPF | Ciprofloxacin | 1 |
| DB00607 | NFN | Nafcillin | 1 |
| DB03279 | LMU | Dodecyl-Alpha-D-Maltoside | 1 |
| DB03825 | RHQ | Rhodamine 6G | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MIY | (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE | 9 |
| ET | ETHIDIUM | 5 |
| 1K8 | 3-chloranyl-2-piperazin-1-yl-quinoline | 4 |
| AV0 | Lauryl Maltose Neopentyl Glycol | 2 |
| CL | CHLORIDE ION | 2 |
| RFP | RIFAMPICIN | 2 |
| CPF | 1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID | 1 |
| CU1metal | COPPER (I) ION | 1 |
| DXT | (4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE | 1 |
| MC2 | N2-(L-PHENYLALANYL)-N1-(NAPHTHALENYL)-L-ARIGNINAMIDE | 1 |
| NAmetal | SODIUM ION | 1 |
| NFN | 6-[[(2-ETHOXY-1-NAPHTHALENYL)CARBONYL]AMINO]-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLATE | 1 |
| RHQ | RHODAMINE 6G | 1 |
| YQM | Eravacycline | 1 |